US5457895A
(en)
*
|
1993-10-01 |
1995-10-17 |
R. P. Scherer Corporation |
Method of identifying freeze-dried dosage forms
|
US5837287A
(en)
*
|
1994-10-28 |
1998-11-17 |
R P Scherer Corporation |
Process for preparing solid pharmaceutical dosage forms
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
AU736912B2
(en)
*
|
1997-02-20 |
2001-08-02 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
US5976577A
(en)
*
|
1997-07-11 |
1999-11-02 |
Rp Scherer Corporation |
Process for preparing fast dispersing solid oral dosage form
|
AU8977698A
(en)
*
|
1997-07-25 |
1999-02-16 |
Elan Corporation, Plc |
A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
|
TW527195B
(en)
|
1997-10-09 |
2003-04-11 |
Ssp Co Ltd |
Fast-soluble solid pharmaceutical combinations
|
ATE259220T1
(de)
|
1998-05-29 |
2004-02-15 |
Skyepharma Canada Inc |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
SE9803240D0
(sv)
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
RU2233654C2
(ru)
|
1998-11-20 |
2004-08-10 |
Ртп Фарма Инк. |
Диспергируемые стабилизированные фосфолипидом микрочастицы
|
US6552024B1
(en)
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
GB9901819D0
(en)
*
|
1999-01-27 |
1999-03-17 |
Scherer Corp R P |
Pharmaceutical compositions
|
GB9908014D0
(en)
*
|
1999-04-08 |
1999-06-02 |
Scherer Corp R P |
Pharmaceutical compositions
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
IL148685A0
(en)
*
|
1999-09-21 |
2002-09-12 |
Rtp Pharma Inc |
Surface modified particulate compositions of biologically active substances
|
BR0007360A
(pt)
*
|
1999-12-23 |
2001-08-14 |
Johnson & Johnson |
Composição de liberação controlada
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
EP1301177A2
(en)
*
|
2000-07-10 |
2003-04-16 |
Therics, Inc. |
Method and materials for controlling migration of binder liquid in a powder
|
IN192750B
(es)
*
|
2000-12-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US6814978B2
(en)
|
2000-12-29 |
2004-11-09 |
Mcneil-Ppc, Inc. |
Process for preparing a soft tablet
|
AU2002247019C1
(en)
*
|
2001-01-26 |
2017-05-11 |
Organon Llc |
Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
US6509040B1
(en)
|
2001-06-22 |
2003-01-21 |
R.P. Scherer Corporation |
Fast dispersing dosage forms essentially free of mammalian gelatin
|
US20030153590A1
(en)
*
|
2001-08-14 |
2003-08-14 |
Oy Contral Pharma Ltd |
Method of treating alcoholism or alcohol abuse
|
DK1443912T3
(da)
|
2001-10-12 |
2008-01-21 |
Elan Pharma Int Ltd |
Sammensætninger med en kombination af umiddelbare og kontrollerede frisætningsegenskaber
|
ATE516799T1
(de)
*
|
2002-02-13 |
2011-08-15 |
Michael K Weibel |
Arzneimitteldosenform und -herstellungsverfahren
|
CA2479735C
(en)
*
|
2002-03-20 |
2011-05-17 |
Elan Pharma International Ltd. |
Fast dissolving dosage forms having reduced friability
|
US20030215498A1
(en)
*
|
2002-05-17 |
2003-11-20 |
Harland Ronald S. |
Rapidly disintegrating comressed tablets comprising biologically active compounds
|
WO2004000223A2
(en)
*
|
2002-06-20 |
2003-12-31 |
Orapharma, Inc. |
Rapidly disintegrating formulations for treating or preventing mucositis
|
WO2004043440A1
(en)
*
|
2002-11-12 |
2004-05-27 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
EP2047865A1
(en)
|
2002-12-03 |
2009-04-15 |
Celltran Limited |
Pharmaceutical compositions of cell lysate and processes for the production and use thereof
|
EP1601669B1
(en)
|
2003-03-07 |
2008-12-24 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
ES2311806T3
(es)
*
|
2003-03-07 |
2009-02-16 |
Schering Corporation |
Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
US20040234579A1
(en)
*
|
2003-05-22 |
2004-11-25 |
Mark D. Finke, Inc. |
Dietary supplements and methods of preparing and administering dietary supplements
|
US20050036977A1
(en)
*
|
2003-08-11 |
2005-02-17 |
Dilip Gole |
Taste-masked resinate and preparation thereof
|
US7282217B1
(en)
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
EP2322197A2
(en)
|
2003-11-10 |
2011-05-18 |
Reprise Biopharmaceutics, LLC |
Pharmaceutical compositions including low dosages of desmopressin
|
DE20321887U1
(de)
|
2003-11-10 |
2012-01-20 |
Allergan, Inc. |
Arzneimittel umfassend niedrige Dosierungen von Desmopressin
|
KR101264444B1
(ko)
|
2004-09-21 |
2013-05-20 |
히프니언 인크. |
록사핀 유사체 및 이것의 사용 방법
|
EP2388263A1
(en)
|
2005-08-04 |
2011-11-23 |
Sirtris Pharmaceuticals, Inc. |
Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
|
GB0516604D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sandoz Ag |
Rapidly dispersing/disintegrating compositions
|
US8158152B2
(en)
*
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
EP1978939A2
(en)
*
|
2005-12-27 |
2008-10-15 |
Jubilant Organosys Limited |
Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxine
|
US20070243248A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Cherukuri S Rao |
Rapidly disintegrating solid oral dosage form of liquid dispersions
|
WO2007130373A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Capricorn Pharma, Inc. |
Novel triptan formulations and methods for making them
|
US20070293582A1
(en)
*
|
2006-06-05 |
2007-12-20 |
Malcolm Hill |
Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
|
US20070293580A1
(en)
*
|
2006-06-05 |
2007-12-20 |
Malcolm Hill |
Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
|
AR061485A1
(es)
*
|
2006-06-15 |
2008-08-27 |
Serenex Inc |
Composiciones estabilizadas de tetraciclina
|
PT2041071E
(pt)
|
2006-06-29 |
2014-09-23 |
Kinex Pharmaceuticals Llc |
Composições de biarilo e processos para a regulação de uma cascata de cinases
|
RU2472493C2
(ru)
*
|
2007-05-08 |
2013-01-20 |
Геркулес Инкорпорейтед |
Композиция прочной быстро распадающейся таблетки
|
EP2170282A4
(en)
*
|
2007-06-27 |
2014-11-05 |
Hanmi Pharm Ind Co Ltd |
METHOD FOR PREPARING RAPID DISAGGREGATION FORMULATION FOR ORAL ADMINISTRATION AND APPARATUS FOR PREPARING AND PACKAGING THEREFOR
|
US20090060983A1
(en)
*
|
2007-08-30 |
2009-03-05 |
Bunick Frank J |
Method And Composition For Making An Orally Disintegrating Dosage Form
|
AU2008314569B2
(en)
|
2007-10-20 |
2014-10-02 |
Atnx Spv, Llc |
Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
|
CA2704209C
(en)
*
|
2007-10-31 |
2017-02-28 |
Mcneil-Ppc, Inc. |
Orally disintegrative dosage form
|
US20090226522A1
(en)
*
|
2008-02-28 |
2009-09-10 |
Howes Simon A M |
Process to minimize polymorphism
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US20100111845A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Compositions and methods for therapeutic delivery with frozen particles
|
US8409376B2
(en)
|
2008-10-31 |
2013-04-02 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8221480B2
(en)
|
2008-10-31 |
2012-07-17 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US9050070B2
(en)
*
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9072688B2
(en)
*
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US9060934B2
(en)
*
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8545856B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8788211B2
(en)
*
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US8603494B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8731840B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8762067B2
(en)
*
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
US8545857B2
(en)
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8731841B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8849441B2
(en)
*
|
2008-10-31 |
2014-09-30 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
US20100111834A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Compositions and methods for therapeutic delivery with frozen particles
|
US8603495B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US9050317B2
(en)
*
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060926B2
(en)
*
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8725420B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8551505B2
(en)
*
|
2008-10-31 |
2013-10-08 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8545855B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8721583B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US20100111857A1
(en)
|
2008-10-31 |
2010-05-06 |
Boyden Edward S |
Compositions and methods for surface abrasion with frozen particles
|
US8793075B2
(en)
|
2008-10-31 |
2014-07-29 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US20110150765A1
(en)
*
|
2008-10-31 |
2011-06-23 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Frozen compositions and methods for piercing a substrate
|
KR101075556B1
(ko)
*
|
2008-11-21 |
2011-10-20 |
씨제이제일제당 (주) |
구강내 속붕해정 및 그 제조방법
|
US8545879B2
(en)
|
2009-08-31 |
2013-10-01 |
Wilmington Pharmaceuticals, Llc |
Fast disintegrating compositions of meloxicam
|
US8858210B2
(en)
|
2009-09-24 |
2014-10-14 |
Mcneil-Ppc, Inc. |
Manufacture of variable density dosage forms utilizing radiofrequency energy
|
US8871263B2
(en)
*
|
2009-09-24 |
2014-10-28 |
Mcneil-Ppc, Inc. |
Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
US20110070286A1
(en)
*
|
2009-09-24 |
2011-03-24 |
Andreas Hugerth |
Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
|
TR201002084A1
(tr)
|
2010-03-19 |
2011-10-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
|
EP2377522B1
(en)
|
2010-04-15 |
2013-01-16 |
Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi |
Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
|
MX2013002430A
(es)
|
2010-09-01 |
2013-07-22 |
Arena Pharm Inc |
Formas de dosis de disolucion de rápida de agonistas de 5-ht2c.
|
WO2012056319A1
(en)
|
2010-10-27 |
2012-05-03 |
Dynamix Pharmaceuticals Ltd. |
Sulfonamides for the modulation of pkm2
|
EP2655334B1
(en)
|
2010-12-22 |
2018-10-03 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
WO2012122370A2
(en)
|
2011-03-08 |
2012-09-13 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
WO2012160447A1
(en)
|
2011-05-25 |
2012-11-29 |
Dynamix Pharmaceuticals Ltd. |
3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
|
CA2837268C
(en)
|
2011-06-07 |
2020-05-12 |
Oren M. Becker |
Compositions and methods for modulating a kinase
|
EP2609911A1
(en)
|
2011-12-29 |
2013-07-03 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
A novel process for preparing orally disintegrating flurbiprofen formulations
|
US9233491B2
(en)
|
2012-05-01 |
2016-01-12 |
Johnson & Johnson Consumer Inc. |
Machine for production of solid dosage forms
|
US9445971B2
(en)
|
2012-05-01 |
2016-09-20 |
Johnson & Johnson Consumer Inc. |
Method of manufacturing solid dosage form
|
US9511028B2
(en)
|
2012-05-01 |
2016-12-06 |
Johnson & Johnson Consumer Inc. |
Orally disintegrating tablet
|
US20150150869A1
(en)
|
2012-06-20 |
2015-06-04 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
SI2890680T1
(en)
|
2012-08-30 |
2018-08-31 |
Athenex, Inc. Conventus Building |
N- (3-FLUOROBENZYL) -2- (5- (4-MORFOLINOPHENYL) PIRIDIN-2-IL) ACETAMIDE AS PROTEIN TIROZINE KINASE PROTECTORS
|
AU2014228990B2
(en)
|
2013-03-15 |
2017-02-02 |
Aprecia Pharmaceuticals LLC |
Rapid disperse dosage form containing levetiracetam
|
US9339489B2
(en)
|
2013-03-15 |
2016-05-17 |
Aprecia Pharmaceuticals Company |
Rapid disperse dosage form containing levetiracetam
|
JP6463333B2
(ja)
|
2013-03-15 |
2019-01-30 |
アプレシア・ファーマスーティカルズ・カンパニー |
オキシカルバゼピンの急速分散性の剤形
|
EP2968181B1
(en)
|
2013-03-15 |
2019-10-16 |
Aprecia Pharmaceuticals LLC |
Rapidly dispersible dosage form of topiramate
|
WO2015105992A1
(en)
|
2014-01-10 |
2015-07-16 |
Mcneil-Ppc, Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|
KR102193599B1
(ko)
|
2014-09-17 |
2020-12-21 |
스티어라이프 인디아 프라이빗 리미티드 |
발포성 조성물 및 이의 제조방법
|
ES2882783T3
(es)
|
2014-11-21 |
2021-12-02 |
Biohaven Pharm Holding Co Ltd |
Formulación sublingual de riluzol
|
WO2017098481A1
(en)
|
2015-12-12 |
2017-06-15 |
Steerlife India Private Limited |
Effervescent compositions of metformin and processes for preparation thereof
|
CN105663065A
(zh)
*
|
2016-04-01 |
2016-06-15 |
曾岚 |
一种含疏水性活性物质的冻干舌下片剂及其制备方法
|
DK4019019T3
(da)
|
2016-05-20 |
2024-05-06 |
Biohaven Therapeutics Ltd |
Anvendelse af riluzol, riluzolprodrugs eller riluzolanaloger med immunterapier til cancerbehandling
|
TW202246254A
(zh)
|
2016-08-12 |
2022-12-01 |
美商亞瑟尼克斯公司 |
聯芳組成物和調控激酶級聯之方法
|
FI3562486T3
(fi)
|
2016-12-31 |
2024-06-04 |
Bioxcel Therapeutics Inc |
Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa
|
US10493026B2
(en)
|
2017-03-20 |
2019-12-03 |
Johnson & Johnson Consumer Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|
US9901545B1
(en)
|
2017-04-13 |
2018-02-27 |
Richard C. Fuisz |
Method and composition for making an oral soluble film, containing at least one active agent
|
US10238600B2
(en)
|
2017-04-13 |
2019-03-26 |
Richard C. Fuisz |
Package, system and methods for custody and control of drugs, and method and composition for making an oral soluble film, containing at least one active agent
|
CZ307916B6
(cs)
|
2017-05-08 |
2019-08-21 |
mcePharma s. r. o. |
Orodispergovatelná tableta s biodostupným kurkuminem a její použití
|
JP6572257B2
(ja)
*
|
2017-05-16 |
2019-09-04 |
大塚製薬株式会社 |
アリピプラゾールの経口速溶性組成物
|
SG11202004332XA
(en)
|
2017-11-12 |
2020-06-29 |
Biohaven Pharm Holding Co Ltd |
Use of riluzole prodrugs to treat ataxias
|
SG11202012772XA
(en)
|
2018-06-27 |
2021-01-28 |
Bioxcel Therapeutics Inc |
Film formulations containing dexmedetomidine and methods of producing them
|
EP3883546A1
(en)
|
2018-11-21 |
2021-09-29 |
Rosemont Pharmaceuticals Ltd |
Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
|
US20240024288A1
(en)
|
2019-07-19 |
2024-01-25 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
CN116018131A
(zh)
|
2020-06-26 |
2023-04-25 |
阿普雷奇亚制药有限责任公司 |
具有内腔的快速口腔分散片剂
|
US11672761B2
(en)
|
2020-11-16 |
2023-06-13 |
Orcosa Inc. |
Rapidly infusing platform and compositions for therapeutic treatment in humans
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|